Home › Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis › Minnesota
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis clinical trials in Minnesota
3 studies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis are looking for participants at sites in Minnesota.
Cities in Minnesota
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
- University of Minnesota, Minneapolis
- Mayo Clinic, Rochester
RecruitingPhase 4
Ages 18 to 100 · All sexes · Updated Sep 30, 2026 · NCT06072482A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Minneapolis
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Aug 7, 2026 · NCT06733935A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- University of Minnesota Medical School, Minneapolis
RecruitingPhase 1
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.